SH2 and SH3 domains as targets for anti-proliferative agents
- 25 October 2001
- journal article
- review article
- Published by Elsevier
- Vol. 40 (2) , 175-186
- https://doi.org/10.1016/s1040-8428(01)00142-1
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Src homology-2 domains: Structure, mechanisms, and drug discoveryBiopolymers, 1998
- Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligandsJournal of Molecular Biology, 1998
- Exploring the Leucine-Proline Binding Pocket of the Src SH3 Domain Using Structure-Based, Split-Pool Synthesis and Affinity-Based SelectionJournal of the American Chemical Society, 1998
- Design, Synthesis, and Cocrystal Structure of a Nonpeptide Src SH2 Domain LigandJournal of Medicinal Chemistry, 1997
- Inhibition of Grb2 and Crkl Proteins Results in Growth Inhibition of Philadelphia Chromosome Positive Leukemic CellsBiochemical and Biophysical Research Communications, 1997
- Crystal Structure of the Mammalian Grb2 AdaptorScience, 1995
- SH3 Domains: Molecular ‘Velcro’Current Biology, 1994
- Identification of a Ten-Amino Acid Proline-Rich SH3 Binding SiteScience, 1993
- SH3 — an abundant protein domain in search of a functionFEBS Letters, 1992
- DNA polyintercalation: comparison of DNA binding properties of an acridine dimer and trimerFEBS Letters, 1984